Jennison Associates LLC Merck & Co., Inc. Transaction History

Jennison Associates LLC

  • $160 Billion
  • Q3 2024

A detailed history of Jennison Associates LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Jennison Associates LLC holds 1,080,765 shares of MRK stock, worth $106 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
1,080,765
Previous 1,809,521 40.27%
Holding current value
$106 Million
Previous $224 Million 45.21%
% of portfolio
0.08%
Previous 0.14%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024
SELL
$111.15 - $128.97 $81 Million - $94 Million
-728,756 Reduced 40.27%
1,080,765 $123 Million
Q2 2024

Aug 05, 2024
BUY
$123.8 - $132.96 $28.4 Million - $30.5 Million
229,126 Added 14.5%
1,809,521 $224 Million
Q1 2024

May 02, 2024
SELL
$113.24 - $131.95 $2.34 Million - $2.72 Million
-20,623 Reduced 1.29%
1,580,395 $209 Million
Q4 2023

Feb 01, 2024
BUY
$100.18 - $109.02 $3.78 Million - $4.12 Million
37,765 Added 2.42%
1,601,018 $175 Million
Q3 2023

Oct 31, 2023
SELL
$102.95 - $114.33 $5.66 Million - $6.29 Million
-55,015 Reduced 3.4%
1,563,253 $161 Million
Q2 2023

Aug 03, 2023
BUY
$108.61 - $118.38 $46.7 Million - $50.9 Million
430,320 Added 36.22%
1,618,268 $187 Million
Q1 2023

Apr 26, 2023
SELL
$102.94 - $114.86 $19.9 Million - $22.2 Million
-193,606 Reduced 14.01%
1,187,948 $126 Million
Q4 2022

Feb 09, 2023
BUY
$87.44 - $112.11 $45.1 Million - $57.8 Million
515,532 Added 59.53%
1,381,554 $153 Million
Q3 2022

Nov 01, 2022
SELL
$84.53 - $94.96 $65.4 Million - $73.5 Million
-773,717 Reduced 47.19%
866,022 $74.6 Million
Q2 2022

Aug 02, 2022
BUY
$83.49 - $94.64 $124 Million - $141 Million
1,489,602 Added 992.16%
1,639,739 $149 Million
Q1 2022

May 11, 2022
BUY
$73.51 - $82.4 $11 Million - $12.4 Million
150,137 New
150,137 $12.3 Million
Q4 2020

Feb 05, 2021
SELL
$71.77 - $79.65 $1.83 Million - $2.04 Million
-25,565 Closed
0 $0
Q3 2020

Nov 04, 2020
SELL
$73.18 - $82.95 $7.79 Million - $8.83 Million
-106,459 Reduced 80.64%
25,565 $2.12 Million
Q2 2020

Aug 06, 2020
SELL
$70.42 - $80.13 $38.1 Million - $43.3 Million
-540,663 Reduced 80.37%
132,024 $10.2 Million
Q1 2020

May 06, 2020
SELL
$63.36 - $87.82 $373,760 - $518,050
-5,899 Reduced 0.87%
672,687 $51.8 Million
Q4 2019

Feb 07, 2020
SELL
$77.58 - $87.54 $22.7 Million - $25.6 Million
-292,958 Reduced 30.15%
678,586 $61.7 Million
Q3 2019

Nov 08, 2019
SELL
$76.08 - $82.93 $65.1 Million - $71 Million
-855,884 Reduced 46.84%
971,544 $78 Million
Q2 2019

Aug 06, 2019
SELL
$69.84 - $81.59 $769 Million - $898 Million
-11,008,666 Reduced 85.76%
1,827,428 $0
Q1 2019

May 10, 2019
SELL
$69.58 - $79.36 $205 Million - $233 Million
-2,941,192 Reduced 18.64%
12,836,094 $1.07 Billion
Q4 2018

Feb 06, 2019
BUY
$65.24 - $75.71 $786 Million - $912 Million
12,048,406 Added 323.11%
15,777,286 $1.21 Billion
Q3 2018

Nov 08, 2018
BUY
$57.69 - $67.84 $162 Million - $190 Million
2,803,934 Added 303.15%
3,728,880 $265 Million
Q2 2018

Aug 02, 2018
BUY
$50.83 - $59.72 $4.67 Million - $5.49 Million
91,879 Added 11.03%
924,946 $56.1 Million
Q1 2018

Apr 20, 2018
SELL
$50.96 - $59.23 $7.58 Million - $8.8 Million
-148,654 Reduced 15.14%
833,067 $45.4 Million
Q4 2017

Jan 25, 2018
SELL
$51.62 - $61.64 $48.7 Million - $58.1 Million
-942,644 Reduced 48.98%
981,721 $55.2 Million
Q3 2017

Nov 03, 2017
BUY
$58.67 - $63.13 $113 Million - $121 Million
1,924,365
1,924,365 $123 Million

Others Institutions Holding MRK

# of Institutions
3,827
Shares Held
1.87B
Call Options Held
15.6M
Put Options Held
13.7M
View Full List

About Merck & Co., Inc.

MRK Quotes by TradingView
  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $248B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Jennison Associates LLC Portfolio

Follow Jennison Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jennison Associates LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email